News Conference News ISC 2026 OCEANIC-STROKE: Asundexian Prevents Recurrent Strokes, With No Added Bleeding Todd Neale February 09, 2026
News Conference News ESOC 2024 Colchicine Misses in Secondary Stroke Prevention, but Door Not Closed Yet Todd Neale May 16, 2024
News Daily News Antihypertensives Linked to Lower Long-term Dementia Risk Caitlin E. Cox April 01, 2024
News ESC 2023 Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST Michael O'Riordan August 27, 2023
News Conference News ESOC 2023 ARCADIA: Apixaban No Help for ESUS Patients With Atrial Cardiopathy Todd Neale May 25, 2023
News Conference News EAS 2022 Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering Michael O'Riordan May 24, 2022
News Conference News ACC 2022 New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More Shelley Wood April 01, 2022
News Conference News TCT 2021 Failed MitraClip Is Uncommon, but Bleak When It Happens Michael O'Riordan October 08, 2021
News Daily News Milrinone, Dobutamine Comparable for Cardiogenic Shock: DOREMI Todd Neale August 10, 2021
News Conference News ESC 2020 VOYAGER PAD: CAD Subanalysis Finds Fewer CV, Limb Events With Rivaroxaban L.A. McKeown September 03, 2020
News Features COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions Shelley Wood July 20, 2020
News Daily News Type 2 MI Linked to More CV Deaths, Even in Younger Patients Shelley Wood March 04, 2020
News Daily News Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward Michael O'Riordan January 09, 2018
News Daily News Platelet Reactivity High in Most Patients Who Develop Stent Thrombosis L.A. McKeown December 20, 2017
News Daily News Genetic Study Hints at Role of Lipids in AAA Risk Michael O'Riordan November 30, 2017